Literature DB >> 12584180

Comparative metabolism of N-nitrosopiperidine and N-nitrosopyrrolidine by rat liver and esophageal microsomes and cytochrome P450 2A3.

Hansen L Wong1, Sharon E Murphy, Mingyao Wang, Stephen S Hecht.   

Abstract

N-nitrosopiperidine (NPIP) is a potent esophageal carcinogen in rats whereas structurally similar N-nitrosopyrrolidine (NPYR) induces liver, but not esophageal tumors. NPIP is a possible causative agent for human esophageal cancer. Our goal is to explain mechanistically these differing carcinogenic activities in the esophagus. We hypothesize that differences in metabolic activation of these nitrosamines could be one factor accounting for their differing carcinogenicity. alpha-Hydroxylation is the key metabolic activation pathway leading to nitrosamine-induced carcinogenesis. In this study, we examined the alpha-hydroxylation rates of [3,4-(3)H]NPIP and [3,4-(3)H]NPYR by male F344 rat esophageal and liver microsomes. The major alpha-hydroxylation products of NPIP and NPYR, 2-hydroxytetrahydro-2H-pyran (2-OH-THP) and 2-hydroxytetrahydrofuran (2-OH-THF), respectively, were monitored by high performance liquid chromatography with radioflow detection. NPIP or NPYR (4 microM) was incubated with varying concentrations of esophageal microsomes and co-factors. Microsomes converted NPIP to 2-OH-THP with a 40-fold higher velocity than NPYR to 2-OH-THF. Similar results were observed in studies with NPIP and NPYR at substrate concentrations between 4 and 100 micro M. Kinetics of NPIP alpha-hydroxylation were biphasic; K(M) values were 312 +/- 50 and 1600 +/- 312 microM. Expressed cytochrome P450 2A3, found in low levels in rat esophagus, was a good catalyst of NPIP alpha-hydroxylation (K(M) = 61.6 +/- 20.5 microM), but a poor catalyst of NPYR alpha-hydroxylation (K(m) = 1198 +/- 308 micro M). Cytochrome P450 2A3 may play a role in the preferential activation of NPIP observed in rat esophagus. Liver microsomes metabolized NPYR to 2-OH-THF (V(max)/K(M) = 3.23 pmol/min/mg/ microM) as efficiently as NPIP to 2-OH-THP (V(max)/K(M) = 3.80-4.61 pmol/min/mg/ microM). We conclude that rat esophageal microsomes activate NPIP but not NPYR whereas rat liver microsomes activate NPIP and NPYR. These results are consistent with previous findings that tissue-specific activation of nitrosamines contributes to tissue-specific tumor formation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12584180     DOI: 10.1093/carcin/24.2.291

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  9 in total

1.  Evaluation of Nitrosamide Formation in the Cytochrome P450-Mediated Metabolism of Tobacco-Specific Nitrosamines.

Authors:  Erik S Carlson; Pramod Upadhyaya; Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2016-12-06       Impact factor: 3.739

2.  Chronic nicotine consumption does not influence 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis.

Authors:  Sharon E Murphy; Linda B von Weymarn; Melissa M Schutten; Fekadu Kassie; Jaime F Modiano
Journal:  Cancer Prev Res (Phila)       Date:  2011-10-25

Review 3.  Metabolic Activation and DNA Interactions of Carcinogenic N-Nitrosamines to Which Humans Are Commonly Exposed.

Authors:  Yupeng Li; Stephen S Hecht
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208

4.  Study on the levels of N-nitrosamine compounds and untargeted metabolomics in patients with colorectal cancer.

Authors:  Zhi Luo; Hetao Wang; Simin Lin; Lili Liao; Lishan Cai; Xiaoxu Zhang; Yangying Tan; Mei Shen
Journal:  Anal Bioanal Chem       Date:  2022-02-16       Impact factor: 4.478

5.  Dietary Dihydromethysticin Increases Glucuronidation of 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol in A/J Mice, Potentially Enhancing Its Detoxification.

Authors:  Sreekanth C Narayanapillai; Linda B von Weymarn; Steven G Carmella; Pablo Leitzman; Jordan Paladino; Pramod Upadhyaya; Stephen S Hecht; Sharon E Murphy; Chengguo Xing
Journal:  Drug Metab Dispos       Date:  2016-01-07       Impact factor: 3.922

6.  Comparison of DNA-Reactive Metabolites from Nitrosamine and Styrene Using Voltammetric DNA/Microsomes Sensors.

Authors:  Sadagopan Krishnan; Besnik Bajrami; Vigneshwaran Mani; Shenmin Pan; James F Rusling
Journal:  Electroanalysis       Date:  2009-03-12       Impact factor: 3.223

7.  Practical and Science-Based Strategy for Establishing Acceptable Intakes for Drug Product N-Nitrosamine Impurities.

Authors:  Krista L Dobo; Michelle O Kenyon; Olivier Dirat; Maria Engel; Andrew Fleetwood; Matthew Martin; Susan Mattano; Alyssa Musso; James Christopher McWilliams; Alexandros Papanikolaou; Patricia Parris; Jessica Whritenour; Shu Yu; Amit S Kalgutkar
Journal:  Chem Res Toxicol       Date:  2022-02-25       Impact factor: 3.739

Review 8.  Effects of bioactive molecules on the concentration of biogenic amines in foods and biological systems.

Authors:  Patrick Blondin Tsafack; Apollinaire Tsopmo
Journal:  Heliyon       Date:  2022-08-29

9.  Dietary N-Nitroso Compounds and Risk of Hepatocellular Carcinoma: A USA-Based Study.

Authors:  Jiali Zheng; Carrie R Daniel; Rikita I Hatia; Janice Stuff; Ahmed A Abdelhakeem; Asif Rashid; Yun Shin Chun; Prasun K Jalal; Ahmed O Kaseb; Donghui Li; Manal M Hassan
Journal:  Hepatology       Date:  2021-08-26       Impact factor: 17.425

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.